$634 Million Settlement in OxyContin Case

Steve Lombardi
Attorney
(866) 735-1102 Ext 335
Posted by Steve LombardiSeptember 11, 2007 12:01 AM

The company that produces OxyContin, Purdue Pharma, has agreed to pay a $634 million settlement to the defendants involved in the case. This settlement is 90% of profits that Purdue Pharma made on OxyContin during the offense.

Purdue Pharma admitted that some of its employees violated prescription regulations for OxyContin, a strong painkiller.

The company also acknowledged that its "fraudulent conduct caused a greater amount of OxyContin to be available for illegal use than otherwise would have been available."

The company has said that three of its top executives will be charged with felonies, as will the company itself.

For more information on this subject matter, please refer to the section on Drugs, Medical Devices, and Implants.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Des Moines

InjuryBoard Des Moines RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Meet your local
Des Moines, Iowa
InjuryBoard Firm
The Lombardi Law Firm (866) 735-1102 Ext 335 www.lombardilaw.com/
google
Personal Injury Lawyers Serving: Ames, Ankeny, Boone, Clive, Des Moines, Grinnell, Jefferson, Leon, Marshalltown, Newton, Osceola, Oskaloosa, Ottumwa, Urbandalte, West Des Moines, Winterset
4200 Corporate DriveSuite 112, West Des Moines, Iowa 50266 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address